A pioneer in biometric-sensor based medical devices; committed to earlier diagnosis and targeted intervention for chronic conditions
Bruin Biometrics, LLC (“BBI”) is a multi-member partnership formed in 2009 and has exclusively licensed wireless health technologies from the UCLA Wireless Health Institute. BBI’s mission is to develop a robust portfolio of patent-protected, FDA-approved wireless health devices targeting significant medical conditions and unmet medical needs. The lead product under development is the Sub-Epidermal Moisture (“SEM”) Scanner Device used to detect pressure ulcers.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2018 | Grant | $1.40M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | — | Grant |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — | Grant |